Neovasc Inc. Return on Tangible Assets

Return on Tangible Assets of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Return on Tangible Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Return on Tangible Assets for 2021 was -48.56% (a -84.4% decrease from previous year)
  • Annual Return on Tangible Assets for 2020 was -311.38% (a -145.19% decrease from previous year)
  • Annual Return on Tangible Assets for 2019 was 689.0% (a -146.08% decrease from previous year)
  • Twelve month Return on Tangible Assets ending March 31, 2022 was -73.63% (a 50.79% increase compared to previous quarter)
  • Twelve month trailing Return on Tangible Assets increased by 73.33% year-over-year
Trailing Return on Tangible Assets for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-73.63% -48.83% -41.75% -42.48%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Return on Tangible Assets of Neovasc Inc.

Most recent Return on Tangible Assetsof NVCN including historical data for past 10 years.

Interactive Chart of Return on Tangible Assets of Neovasc Inc.

Neovasc Inc. Return on Tangible Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -48.56%
2020 -311.38%
2019 689.0%
2018 -1495.17%
2017 542.37%
2016 543.57%
2015 -46.09%
2014 -94.56%
2013 -115.93%
2012 -4.56%
2011 -68.68%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.